To evaluate the health benefits, costs, and cost-effectiveness of jail-based hepatitis C virus (HCV) elimination strategies specifically targeting people who inject drugs.
Key Findings:
Jail-based HCV interventions can significantly reduce viremia prevalence, indicating a direct impact on public health.
Direct-acting antiviral treatments enhance the feasibility of jail-based HCV care, suggesting a shift in treatment paradigms.
High loss to follow-up was observed due to early release before treatment completion, highlighting a critical barrier to effective care.
Interpretation:
Jail settings present unique opportunities and challenges for HCV elimination efforts, with potential public health benefits such as reduced transmission rates, despite financial disincentives for jails.
Limitations:
Short detention periods may hinder sufficient time for HCV testing and treatment, necessitating streamlined processes.
Staff shortages and turnover in jails complicate healthcare delivery, indicating a need for stable staffing solutions.
Conclusion:
Innovative jail-based HCV elimination strategies are essential for reaching and engaging people who inject drugs, potentially leading to broader community health benefits and addressing systemic barriers.
by Lin Zhu, Lora N. Magaldi, Indrani A. Wagh, Eliza R. Ennis, Marissa B. Reitsma, Danica E. Kuncio, Eman Addish, Sandy R. Varghese, Nathan W. Furukawa, Amanda A. Honeycutt, Yijie Chen, Benjamin P. Linas, Joshua A. Salomon
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
